Compulsory License Battle Moves To Indian Court

Law360, New York (March 13, 2008, 12:00 AM EDT) -- Heating up the controversy over compulsory licensing, the High Court of Delhi reportedly is set to consider whether Indian generics manufacturer Natco Pharma should be allowed to override patents on cancer drugs made by Pfizer Inc. and F. Hoffmann-La Roche Ltd.

The case, which is the first to center on the divisive issue of compulsory licensing since India revamped its patent laws in January 2005, will be heard in the High Court this week, the Wall Street Journal Asia said Thursday.

The battle began in February,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.